Prevalence and Factors Associated With Fecal Urgency Among Patients With Ulcerative Colitis and Crohn's Disease in the Study of a Prospective Adult Research Cohort With Inflammatory Bowel Disease

Overview

Journal Crohns Colitis 360

Publisher Oxford University Press

Date 2023 Feb 13

PMID 36776663

Authors

Ghadeer K Dawwas

Hamzeh Jajeh

Mingyang Shan

April N Naegeli

Theresa Hunter

James D Lewis

Affiliations

Soon will be listed here.

Abstract

Background: In patients with ulcerative colitis (UC) and Crohn's disease (CD), this research examined the following: prevalence of fecal urgency (hereafter urgency), association of urgency with inflammatory bowel disease (IBD) symptoms and fecal calprotectin, and association between well-being and urgency.

Methods: In this cross-sectional study from the Study of a Prospective Adult Research Cohort with IBD, urgency was categorized as none, mild, and moderate-severe. We examined the prevalence of urgency, association of urgency with IBD symptoms and fecal calprotectin (in a subset) using multinomial logistic regression, and association of well-being (not feeling well vs generally well) with urgency using logistic regression.

Results: Among 576 UC patients, 31.4% reported mild and 28.1% moderate-severe urgency. Among 1330 CD patients, 33.8% reported mild and 31.4% moderate-severe urgency. In UC, moderate-severe urgency was associated with: increased average bowel movements/day [odds ratio (OR) 1.23; 95% confidence interval: 1.09, 1.23], increased stool frequency relative to normal (OR, 9.95; 95% CI: 3.21, 30.87), rectal bleeding (OR, 3.36; 95% CI: 1.79, 6.34), moderate-severe abdominal pain (OR, 17.5; 95% CI: 5.38, 56.89), and calprotectin ≥ 250 μg/g (OR, 4.36; 95% CI: 1.50, 12.66). In CD, moderate-severe urgency was associated with: increased average bowel movements/day (OR, 1.23; 95% CI: 1.14, 1.34), increased stool frequency relative to normal (OR, 7.57; 95% CI: 3.30, 17.34), rectal bleeding (OR, 1.77; 95% CI: 1.13, 2.78), and moderate-severe abdominal pain (OR, 7.52; 95% CI: 4.31, 13.14). Reduced well-being was associated with moderate-severe urgency in both UC (OR, 4.20; 95% CI: 1.69, 20.40) and CD patients (OR, 2.52; 95% CI: 1.51, 4.22).

Conclusions: Urgency was common and associated with symptoms and biomarkers suggesting active IBD and reduced well-being.

Citing Articles

Switching to Subcutaneous Infliximab Maintenance Therapy Is Effective in Patients with Inflammatory Bowel Disease.

Rautakorpi J, Kolehmainen S, Loyttyniemi E, Af Bjorkesten C, Arkkila P, Sipponen T Dig Dis Sci. 2025; .

PMID: 39946070 DOI: 10.1007/s10620-025-08876-5.

The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn's Disease.

Dubinsky M, Vadhariya A, Su S, Zhou X, Durand F, Clucas C Adv Ther. 2024; 42(2):1044-1060.

PMID: 39692838 PMC: 11787167. DOI: 10.1007/s12325-024-03081-8.

Patient perception of bowel urgency and remission in moderately to severely active Crohn's disease or ulcerative colitis: a qualitative study.

Hunter Gibble T, Stassek L, Harding G, Stefan M, Fikre T, Potts Bleakman A J Patient Rep Outcomes. 2024; 8(1):130.

PMID: 39531103 PMC: 11557785. DOI: 10.1186/s41687-024-00800-1.

Burden of Bowel Urgency in Patients With Ulcerative Colitis and Crohn's Disease: A Real-World Global Study.

Atreya R, Redondo I, Streit P, Protic M, Hartz S, Gurses G Crohns Colitis 360. 2024; 6(3):otae047.

PMID: 39281848 PMC: 11401995. DOI: 10.1093/crocol/otae047.

The Clinical Course of Bowel Urgency Severity Among Patients with Inflammatory Bowel Disease-A Real-World Study.

Lewis J, Hunter Gibble T, Shan M, Zhou X, Naegeli A, Dawwas G Drugs Real World Outcomes. 2024; 11(3):403-412.

PMID: 38878264 PMC: 11365885. DOI: 10.1007/s40801-024-00434-1.

References

Lichtenstein G, Feagan B, Cohen R, Salzberg B, Diamond R, Price S . Serious infection and mortality in patients with Crohn's disease: more than 5 years of follow-up in the TREAT™ registry. Am J Gastroenterol. 2012; 107(9):1409-22. PMC: 3438468. DOI: 10.1038/ajg.2012.218. View

Rao S, HOLDSWORTH C, Read N . Symptoms and stool patterns in patients with ulcerative colitis. Gut. 1988; 29(3):342-5. PMC: 1433596. DOI: 10.1136/gut.29.3.342. View

Nobrega V, Silva I, Brito B, Silva J, Silva M, Santana G . THE ONSET OF CLINICAL MANIFESTATIONS IN INFLAMMATORY BOWEL DISEASE PATIENTS. Arq Gastroenterol. 2018; 55(3):290-295. DOI: 10.1590/S0004-2803.201800000-73. View

Longobardi T, Jacobs P, Bernstein C . Utilization of health care resources by individuals with inflammatory bowel disease in the United States: a profile of time since diagnosis. Am J Gastroenterol. 2004; 99(4):650-5. DOI: 10.1111/j.1572-0241.2004.04132.x. View

Rangan V, Mitsuhashi S, Singh P, Ballou S, Hirsch W, Sommers T . Risk Factors for Fecal Urgency Among Individuals With and Without Diarrhea, Based on Data From the National Health and Nutrition Examination Survey. Clin Gastroenterol Hepatol. 2018; 16(9):1450-1458.e2. PMC: 6098738. DOI: 10.1016/j.cgh.2018.02.020. View

Alibrahim B, AlJasser M, Salh B . Fecal calprotectin use in inflammatory bowel disease and beyond: A mini-review. Can J Gastroenterol Hepatol. 2015; 29(3):157-63. PMC: 4399376. DOI: 10.1155/2015/950286. View

Walter S, Hjortswang H, Holmgren K, Hallbook O . Association between bowel symptoms, symptom severity, and quality of life in Swedish patients with fecal incontinence. Scand J Gastroenterol. 2010; 46(1):6-12. DOI: 10.3109/00365521.2010.513059. View

Drossman D, Sandler R, Broom C, MCKEE D . Urgency and fecal soiling in people with bowel dysfunction. Dig Dis Sci. 1986; 31(11):1221-5. DOI: 10.1007/BF01296523. View

Dibley L, Bager P, Czuber-Dochan W, Farrell D, Jelsness-Jorgensen L, Kemp K . Identification of Research Priorities for Inflammatory Bowel Disease Nursing in Europe: a Nurses-European Crohn's and Colitis Organisation Delphi Survey. J Crohns Colitis. 2016; 11(3):353-359. DOI: 10.1093/ecco-jcc/jjw164. View

10.

Panaccione R . Mechanisms of inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2014; 9(8):529-32. PMC: 3980998. View

11.

Singh P, Takazawa E, Rangan V, Ballou S, Katon J, McMahon C . Fecal urgency is common in constipated patients and is associated with anxiety. Neurogastroenterol Motil. 2019; 31(4):e13545. PMC: 6414071. DOI: 10.1111/nmo.13545. View

12.

DHaens G, Sandborn W, Feagan B, Geboes K, Hanauer S, Irvine E . A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology. 2007; 132(2):763-86. DOI: 10.1053/j.gastro.2006.12.038. View

13.

Zeitz J, Ak M, Muller-Mottet S, Scharl S, Biedermann L, Fournier N . Pain in IBD Patients: Very Frequent and Frequently Insufficiently Taken into Account. PLoS One. 2016; 11(6):e0156666. PMC: 4917102. DOI: 10.1371/journal.pone.0156666. View

14.

Sipponen T, Nuutinen H, Turunen U, Farkkila M . Endoscopic evaluation of Crohn's disease activity: comparison of the CDEIS and the SES-CD. Inflamm Bowel Dis. 2010; 16(12):2131-6. DOI: 10.1002/ibd.21300. View

15.

Lewis J, Rutgeerts P, Feagan B, DHaens G, Danese S, Colombel J . Correlation of Stool Frequency and Abdominal Pain Measures With Simple Endoscopic Score for Crohn's Disease. Inflamm Bowel Dis. 2019; 26(2):304-313. DOI: 10.1093/ibd/izz241. View

16.

Petryszyn P, Paradowski L . Stool patterns and symptoms of disordered anorectal function in patients with inflammatory bowel diseases. Adv Clin Exp Med. 2018; 27(6):813-818. DOI: 10.17219/acem/68986. View